Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds.
about
Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell lineCharacterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cellsThe important molecular markers on chromosome 17 and their clinical impact in breast cancerHypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage.Topoisomerase II poisoning by ICRF-193.Dissecting the cell-killing mechanism of the topoisomerase II-targeting drug ICRF-193.
P2860
Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Differential expression of top ...... bisdioxopiperazine compounds.
@en
type
label
Differential expression of top ...... bisdioxopiperazine compounds.
@en
prefLabel
Differential expression of top ...... bisdioxopiperazine compounds.
@en
P2093
P2860
P356
P1476
Differential expression of top ...... bisdioxopiperazine compounds.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690767
P407
P577
1999-11-01T00:00:00Z
P5875
P6179
1001074194